发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING A MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR AND AN ACETYLCHOLINESTERASE INHIBITOR |
摘要 |
The invention relates to a pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (1), and at least one acetylcholinesterase inhibitor or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (2), and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients. |
申请公布号 |
WO2005039580(A1) |
申请公布日期 |
2005.05.06 |
申请号 |
WO2004EP11093 |
申请日期 |
2004.10.05 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG;NEUROSEARCH A/S;FRIEDL, THOMAS;MIERAU, JOACHIM;RASCHIG, ANDREAS;REESS, JUERGEN;SCHEEL-KRUEGER, JOERGEN |
发明人 |
FRIEDL, THOMAS;MIERAU, JOACHIM;RASCHIG, ANDREAS;REESS, JUERGEN;SCHEEL-KRUEGER, JOERGEN |
分类号 |
A61K9/16;A61K9/24;A61K9/28;A61K31/27;A61K31/407;A61K31/445;A61K31/46;A61K31/4706;A61K31/55 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|